In solid tumors, ALK fusions were first identified in inflammatory myofibroblastic tumors, and in 2007 the echinoderm microtubule associated protein like4 (EML4)-ALK fusion protein was reported in non-small cell lung cancer (NSCLC) [10]. Here, ALK is linked to inflammatory myofibroblastic tumor.